Merrimack Pharmaceuticals Price on March 22, 2023
MACKDelisted Stock | USD 11.96 0.12 1.01% |
If you're considering investing in Merrimack Stock, it is important to understand the factors that can impact its price. As of today, the current price of Merrimack Pharmaceuticals stands at 11.96, as last reported on the 30th of November, with the highest price reaching 12.01 and the lowest price hitting 11.84 during the day. We have found twenty-four technical indicators for Merrimack Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please verify Merrimack Pharmaceuticals' Standard Deviation of 1.12, mean deviation of 0.7806, and Risk Adjusted Performance of (0.03) to check out if the risk estimate we provide is consistent with the expected return of 0.0%.
Merrimack Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Merrimack |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
MACK |
Based on monthly moving average Merrimack Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Merrimack Pharmaceuticals by adding Merrimack Pharmaceuticals to a well-diversified portfolio.
Merrimack Pharmaceuticals Valuation on March 22, 2023
It is possible to determine the worth of Merrimack Pharmaceuticals on a given historical date. On March 22, 2023 Merrimack was worth 11.55 at the beginning of the trading date compared to the closed value of 11.73. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Merrimack Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Merrimack Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Merrimack Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Merrimack Pharmaceuticals' related companies.
Open | High | Low | Close | Volume | |
11.56 | 11.65 | 11.45 | 11.56 | 342,095 | |
03/22/2023 | 11.55 | 11.90 | 11.55 | 11.73 | 77,579 |
12.01 | 12.01 | 11.80 | 11.87 | 44,314 |
Backtest Merrimack Pharmaceuticals | | | Merrimack Pharmaceuticals History | | | Merrimack Pharmaceuticals Valuation | Previous | Next |
Merrimack Pharmaceuticals Trading Date Momentum on March 22, 2023
On March 23 2023 Merrimack Pharmaceuticals was traded for 11.87 at the closing time. The top price for the day was 12.01 and the lowest listed price was 11.80 . The trading volume for the day was 44.3 K. The trading history from March 23, 2023 was a factor to the next trading day price upswing. The trading delta at closing time against the next closing price was 1.19% . The trading delta at closing time against the current closing price is 3.75% . |
Merrimack Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Merrimack Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Merrimack Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Merrimack financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Merrimack Pharmaceuticals Stock history
Merrimack Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Merrimack is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Merrimack Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Merrimack Pharmaceuticals stock prices may prove useful in developing a viable investing in Merrimack Pharmaceuticals
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts. Merrimack Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Merrimack Pharmaceuticals Stock Technical Analysis
Merrimack Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Merrimack Pharmaceuticals Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Merrimack Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Merrimack Pharmaceuticals November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Merrimack Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Merrimack Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Merrimack Pharmaceuticals stock market strength indicators, traders can identify Merrimack Pharmaceuticals entry and exit signals to maximize returns
Merrimack Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Merrimack Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Merrimack Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Merrimack to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.03) | |||
Jensen Alpha | (0.06) | |||
Total Risk Alpha | (0.24) | |||
Treynor Ratio | 3.64 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Merrimack Stock
If you are still planning to invest in Merrimack Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Merrimack Pharmaceuticals' history and understand the potential risks before investing.
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |